TRPC6 inhibition for the treatment of focal segmental glomerulosclerosis: a randomised, placebo-controlled, phase 2 trial of BI 764198

The Lancet 2026

View at publisher
Authors: Howard Trachtman, Matthias Kretzler, Loreto Gesualdo, Nicholas Cross, Biruh Workeneh, Jessica Kaufeld, Björn Meijers, Zhiming Ye, Qinkai Chen, Vimal K Derebail, Monica Suet Ying Ng, Bo Ji
+5 more Maximilian T. Lobmeyer, Silke Retlich, Fabia T Licarião Rocha, Srinivasa Prasad, Nima Soleymanlou
DOI: 10.1016/s0140-6736(25)02255-x
Cited by: 12
References: 23

Fields of Study & Subjects

Renal Diseases and Glomerulopathies Chronic Kidney Disease and Diabetes Genetic and Kidney Cyst Diseases

Publication details

Journal / source
The Lancet
Publisher
Elsevier BV
Volume
407
Issue
10528
Pages
587–598
Publication date
27 January 2026
Language
EN